More about our sector?

this is your place

Making the Conversation Real – What To Expect From The AI Manufacturing Team At Xavier University

Making the Conversation Real – What To Expect From The AI Manufacturing Team At Xavier University

 

Artificial Intelligence is no longer an entirely foreign concept in our industry and as companies gradually begin experimenting with these technologies (AI, ML, and big data) in their manufacturing operations, a wave of questions start to surface. How much investment is needed and how do we determine the ROI post-investment?  What will be the regulatory compliance hurdles and how can they be addressed? Where do people fit into all of this? In an attempt to help the pharmaceutical and medical device community adapt to this digital transformation, Xavier Health at Xavier University started an Artificial Intelligence Initiative.  The AI Initiative is a small community focused on integrating the implementation of AI in pharmaceutical and medical device manufacturing operations.  This initiative is the framework where different actors are aligned to explore and empower AI implementation in the regulated environment under the life sciences foundation.  There are four working teams: AI Core Team, CPQA Team, CLS Working Team, and the AI In Manufacturing Team.  Each team is made up of FDA and industry professionals, working collaboratively to address various obstacles from increasing the assurance of product quality through the power of AI to setting a vision and strategy for the AI Intelligence Initiative Core Team.         

As a company that understands first hand the journey companies go through when implementing these new technologies, it was important for us at Bigfinite to join the organization and contribute to the dialogue.  Our co-founder and R&D Director Toni Manzano is a team lead for Xavier University AI in Manufacturing Team where, with the help of FDA officials and industry professionals, they address how the power of AI can be used to optimize manufacturing operations.  The goal is to define requirements and explore the knowledge we have of AI and apply it to the ‘real world’. They aim to share existing use cases of AI in manufacturing and also show how to implement these technologies in manufacturing operations.  They are working to define AI in manufacturing, publish examples of use cases on pharma and medical device manufacturing using AI, and develop a white paper to capture the learnings developed from the early AI solutions being deployed in manufacturing.

The capabilities operations can achieve with the use of AI is exponential (reduce costs, improve time to market, and better quality).  Companies are exploding with data and rather than letting it sit, stored away in cabinets and data silos, we see a tremendous amount of power in all of that unused data.  This initiative will elevate all of our understanding of how AI works and advance the life sciences industry.

If you are interested in joining the AI in Manufacturing Team, you can sign up here: https://www.xavierhealth.org/ai-initiative-working-teams

Melissa Villalobos

Sales and Marketing Coordinator

Making the Conversation Real – What To Expect From The AI Manufacturing Team At Xavier University

Our co-founder and R&D Director Toni Manzano is a team lead for Xavier University AI in Manufacturing Team where, with the help of FDA officials and industry professionals, they address how the power of AI can be used to optimize manufacturing operations in the life sciences industry.

Taking Smart Manufacturing “Back to The Future”

What does the future look like in a smart factory in the pharma or biotech industry? We believe a smart factory is a digitally transformed facility and operation that is reaping the benefits of increased productivity. In fact, some experts predict an order of magnitude productivity gain! It is this productivity gain we need to aim and think about when talking digital transformation, it is the vision and the clear long-term goal. And yes, it is super important because with a clear goal it is easier to prioritize which technology to try first and where or what to digitally transform first, in other words, the strategy.

AWS re:Invent 2018 is Here!  Are You Ready?

Bigfinite is excited to announce that we will be attending the 2018 AWS re:Invent!  For the past three years, we have attended the annual conference and every year this event has continued to gain tremendous growth and take the city by storm.

Cultural Resistance… Who are the Real Enablers?

Advanced analytics technologies in the pharmaceutical industry are accessible now more than ever and regulators have slowly become more accepting of these kinds of advances.  The introduction of machine learning, artificial intelligence, and big data technologies are disrupting our industry, and it’s time we change our mindset.

Gartner Selects Bigfinite as “2018 Cool Vendor for Life Sciences”

We are excited to share that Bigfinite was selected as a 2018 Gartner Cool Vendor for Life Sciences - the only company solely focused on GxP manufacturing intelligence and analytics!

A story about adoption – Pharma 4.0 at the world’s largest insulin manufacturers

Pharma 4.0 is a popular topic in this years ISPE Annual Meeting event in Philly and currently of great interest in the industry as a whole.

Pharma 4.0 is here – we need to understand the compliance implications of big data and AI

With Pharma 4.0 comes a paradigm shift in many aspects. We in the pharma industry know all too well that every move we make needs to consider compliance with regulation - it's in everything that we do. Yet we can’t ignore the promise that these new technologies come with while at the same time speculating about the regulatory aspects. Although it may seem overwhelming right now, we must change the way we think.  New technologies such as big data, artificial intelligence, machine learning, and deep learning offer unprecedented analysis of real-time data and can even predict trends in processes, operations, and quality. You probably have heard this many times before, but it is truer this time than before.

Welcome to the Bigfinite Blog!

Just like many startups in Silicon Valley, Bigfinite started out as a disruptive idea: solve the current Pharma inefficiencies with the newest AI and cloud technologies.